Current Medicinal Chemistry
Title:Editorial (Hot Topic: Small Non-coding RNAs as Therapeutic Agents or Targets)
Volume: 20 Issue: 29
Author(s): Yan Zhang and Weibo Cai
Affiliation:
Export Options
About this article
Cite this article as:
Zhang Yan and Cai Weibo, Editorial (Hot Topic: Small Non-coding RNAs as Therapeutic Agents or Targets), Current Medicinal Chemistry 2013; 20 (29) . https://dx.doi.org/10.2174/0929867311320290001
DOI https://dx.doi.org/10.2174/0929867311320290001 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
13
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Polo-like Kinase 1-targeting Chitosan Nanoparticles Suppress the Progression of Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Imaging Intraductal Carcinoma
Current Cancer Therapy Reviews Micro-Nanomaterials for Tumor Microwave Hyperthermia: Design, Preparation, and Application
Current Drug Delivery HDL Stimulates apoM Secretion
Protein & Peptide Letters Subject Index To Volume 6
Current Molecular Medicine Preferentially Expressed Antigen in Melanoma (PRAME) and the PRAME Family of Leucine-Rich Repeat Proteins
Current Cancer Drug Targets Design, Synthesis, Crystal Structure, Fluorescence, Molecular Docking and DFT Studies of 3,6-Dinitro-N-octylcarbazole
Current Organic Chemistry Managing Comorbidity in COPD: A Difficult Task
Current Drug Targets Aromatase Inhibitors and Inactivators for the Treatment of Postmenopausal Breast Cancer: A Review
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Recent Advances and Strategies in Tumor Vasculature Targeted Nano-Drug Delivery Systems
Current Pharmaceutical Design The Zinc Metallopeptidase Family: New Faces, New Functions
Protein & Peptide Letters Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Cytochrome P450-Activated Prodrugs: Targeted Drug Delivery
Current Medicinal Chemistry Current Methods and Research Progress in Nanomaterials Risk Assessment
Current Drug Metabolism Polypharmacology of Approved Anticancer Drugs
Current Drug Targets Systemic Drug Delivery Systems for Bone Tissue Regeneration– A Mini Review
Current Pharmaceutical Design Safety of Nanoparticles in Medicine
Current Drug Targets The EGFR Pathway Regulates BCRP Expression in NSCLC Cells: Role of Erlotinib
Current Drug Targets Clinical Trials of Novel Targeted Therapies in Ovarian Cancer: Moving Beyond Poly ADP Ribose Polymerase (PARP) Inhibitors
Current Pharmaceutical Biotechnology Effects of Plants and Isolates of Celastraceae Family on Cancer Pathways
Anti-Cancer Agents in Medicinal Chemistry